Laser in situ keratomileusis with a scanning excimer laser for the correction of low to moderate myopia with and without astigmatism

Abstract

Purpose: To evaluate the safety and effectiveness of and patient satisfaction with laser in situ keratomileusis (LASIK) performed with a scanning excimer laser by experienced surgeons to correct low and moderate levels of myopia and astigmatism. Setting: Clinique Laservue, Montreal, Quebec, Canada. Methods: A consecutive series of 125 patients (236 eyes) with myopia of −0.5 to −7.0 diopters (D) and cylinder less than 2.5 D were enrolled in this single-center prospective clinical trial. The patients were treated with LASIK and followed for 6 months. The System-ALK Automated Corneal Shaper® microkeratome (Bausch & Lomb Surgical) with a 180 μm thickness plate and the Technolas® 217 excimer laser (Bausch & Lomb Surgical) with PlanoScan software for the stromal ablation were used in all procedures. Since this version of PlanoScan tended to undercorrect, a mean of 14.7% was added to the standard nomogram. Patient satisfaction was assessed by questionnaires administered preoperatively and 1 and 6 months postoperatively. Retreatments for enhancement were not performed during the 6-month follow-up. Results: Six months after LASIK (86.4% follow-up), the mean postoperative manifest spherical equivalent was +0.02 D ± 0.64 (SD) compared with a preoperative mean of −4.01 ± 1.59 D. The uncorrected visual acuity was 20/40 or better in 94.6% of eyes and 20/20 or better in 81.9%. A total of 91.2% were within ±1.0 D of emmetropia and 73.0% were within ±0.5 D. Only 2 eyes were overcorrected by >1.0 D. Of the eyes with astigmatic myopia, 86.8% were within ±1.0 D of the intended cylinder correction (by vector analysis) and 73.0% were within ±0.5 D. The refractions were generally stable after 1 month, and the change in refraction between postoperative examinations was within ±0.5 D in 88.0% of eyes. A 1-line decrease in best spectacle-corrected visual acuity was seen in 11.3% of eyes, and no eye lost more than 1 line. An increase of 1 or 2 lines was seen in 45.1%. No intraoperative problems occurred, and the interface was clear in all eyes. At 6 months, most symptoms present significantly more frequently than preoperatively were “mild”; none were “marked” or “severe.” A total of 90.5% of eyes were reported with marked to extreme improvement in the overall quality of vision, and 99.0% of patients said they would choose LASIK surgery again. Conclusions: Mild to moderate myopia, with and without astigmatism, was corrected safely, effectively, and predictably with a high degree of patient satisfaction using LASIK with a scanning excimer laser and the System-ALK Automated Corneal Shaper.